Adjuvant
OwnerNira Hochman, Jacob Hochman +2inventors
InventorsNira Hochman, Jacob Hochman, Ervin Weiss, Itzhak Ofek
Life of this patent
Estimating the term…
Abstract
The subject invention provides new adjuvant therapy.
Claims25
An adjuvant comprising NDM (12-30 K) having a molecular weight of from about 12 to about 30 kDa isolated from Vaccinium.
An adjuvant comprising NDM having a molecular weight of at least about 12 kDa.
A use of pharmaceutical composition comprising NDM having a molecular weight of at least about 12 kDa.
A pharmaceutical composition comprising NDM (12-30 K) having a molecular weight of from about 12 to about 30 kDa.
A fraction of NDM, NDM (12-30 K), having a molecular weight of from about 12 to about 30 kDa isolated from Vaccinium.
Dependencies are inferred from the claim text.